share_log

Jefferies Upgrades Vera Therapeutics to Buy, Raises Price Target to $26

Benzinga ·  Nov 10, 2023 05:31

Jefferies analyst Farzin Haque upgrades Vera Therapeutics (NASDAQ:VERA) from Hold to Buy and raises the price target from $18 to $26.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment